The expansion will significantly enhance AbbVie’s ability to meet growing global demand for biologics, particularly in oncology and immunology
India currently hosts more than 10,075 biotech startups
Miels will formally assume the role on January 1, 2026
Amgen has invested over $40 billion in manufacturing and research and development in US since 2017
Sanofi Ventures drives innovation through leading and participating in private financing rounds for pioneering healthcare companies
82,514 sq ft facility to host up to 15 biotech companies, fueling the development of next-generation medicines
Represents one of the largest cell culture biomanufacturing sites in North America, which will employ 1,400 people by 2031
Hengrui is eligible to receive regulatory and commercial milestone payments of up to US$1.093 billion
Pegozafermin offers a distinct mechanism of action with potential for enhanced efficacy and tolerability and opportunities for combination development with incretins
Subscribe To Our Newsletter & Stay Updated
